ISSN 1004-4140
CN 11-3017/P
| Citation: |
CHENG C F, CHEN H L, ZHAI Y N, et al. Advances in Radiomics for Predicting Intraoperative Hemodynamic Instability in Pheochromocytoma Surgery[J]. CT Theory and Applications, xxxx, x(x): 1-6. DOI: 10.15953/j.ctta.2024.248. (in Chinese).
|
Objective Pheochromocytomas present with diverse clinical manifestations, and surgical resection is the optimal treatment. However, intraoperative risks are challenging to assess effectively. Computed tomography (CT) imaging is a crucial tool for localization, diagnosis, and predicting therapeutic efficacy. In recent years, radiomics research based on CT has demonstrated significant advantages and potential applications in tumor differential diagnosis, classification, biological behavior assessment, and intraoperative risk evaluation. Moreover, the development of omics models based on tumor characteristics offers a reliable and non-invasive alternative to guide precision medicine procedures. This study aimed to explore the application and value of CT radiomics in the intraoperative risk assessment of pheochromocytomas, assisting physicians in related departments to better understand the research findings associated with radiomics.
| [1] |
LEUNG A A, PASIEKA J L, HYRCZA M D, ET AL. Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study[J]. European Journal of Endocrinology, 2021, 184(1): 19-28. DOI: 10.1530/EJE-20-0628.
|
| [2] |
EID M, FOUKAL J, SOCHOROVA D, ET AL. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options[J]. Cancer Medicine, 2023, 12(13): 13942-13957. DOI: 10.1002/cam4.6010.
|
| [3] |
GABIACHE G, ZADRO C, ROZENBLUM L, ET AL. Image-guided precision medicine in the diagnosis and treatment of pheochromocytomas and paragangliomas[J]. Cancers, 2023, 15(18): 4666. DOI: 10.3390/cancers15184666.
|
| [4] |
BUITENWERF E, OSINGA T E, TIMMERS HJLM, ET AL. Efficacy of α-blockers on hemodynamic control during pheochromocytoma resection: A randomized controlled trial[J]. The Journal of Clinical Endocrinology and Metabolism, 2020, 105(7): 2381-2391. DOI: 10.1210/clinem/dgz188.
|
| [5] |
MA L, SHEN L, ZHANG X, ET AL. Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma[J]. Journal of Surgical Oncology, 2020, 122(4): 803-808. DOI: 10.1002/jso.26079.
|
| [6] |
KIM J H, LEE H C, KIM S J, ET AL. Perioperative hemodynamic instability in pheochromocytoma and sympathetic paraganglioma patients[J]. Scientific Reports, 2021, 11(1): 18574. DOI: 10.1038/s41598-021-97964-3.
|
| [7] |
FU Y, WANG X, YI X, ET AL. Ensemble machine learning model incorporating radiomics and body composition for predicting intraoperative HDI in PPGL[J]. The Journal of Clinical Endocrinology and Metabolismb, 2024, 109(2): 351-360. DOI: 10.1210/clinem/dgad543.
|
| [8] |
ZHANG Z, YE Y, YU J, et al. A nomogram for predicting intraoperative hemodynamic instability in patients with pheochromocytoma[J]. Frontiers in Endocrinology (Lausanne). 2022, 12: 787786. DOI: 10.3389/fendo.2021.787786.
|
| [9] |
OHMACHI Y, YAMAMOTO M, INABA Y, ET AL. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas[J]. Endocrine, 2024, 84(2): 694-703. DOI: 10.1007/s12020-023-03681-4.
|
| [10] |
DE FILPO G, PARENTI G, SPARANO C, ET AL. Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: A retrospective study[J]. World Journal of Surgical Oncology, 2023, 21(1): 192. DOI: 10.1186/s12957-023-03072-z.
|
| [11] |
BAI S, WU B, YAO Z, ET AL. Development and validation of a clinical model to predict intraoperative hemodynamic instability in patients with pheochromocytomas surgery[J]. Endocrine Journal, 2020, 67(1): 81-89. DOI: 10.1507/endocrj.EJ19-0278.
|
| [12] |
EBBEHOJ A, STOCHHOLM K, JACOBSEN S F, ET AL. Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: A population-based study[J]. The Journal of Clinical endocrinology and Metabolism, 2021, 106(5): e2251-e2261. DOI: 10.1210/clinem/dgaa965.
|
| [13] |
ROGACEV K S, CREMERS B, ZAWADA A M, ET AL. CD14++CD16+ monocytes independently predict cardiovascular events: A cohort study of 951 patients referred for elective coronary angiography[J]. Journal of the American College of Cardiology, 2012, 60(16): 1512-1520. DOI: 10.1016/j.jacc.2012.07.019.
|
| [14] |
VAN DER HEIJDEN C D C C, GROH L, KEATING S T, ET AL. Catecholamines induce trained immunity in monocytes in vitro and in vivo[J]. Circulation Research, 2020, 127(2): 269-283. DOI: 10.1161/CIRCRESAHA.119.315800.
|
| [15] |
PANG Y, LI M, JIANG J, ET AL. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma[J]. Journal of Cachexia, Sarcopenia and Muscle, 2022, 13(6): 2843-2853. DOI: 10.1002/jcsm.13071.
|
| [16] |
NöLTING S, BECHMANN N, TAIEB D, ET AL. Personalized management of pheochromocytoma and paraganglioma[J]. Endocrine Reviews, 2022, 43(2): 199-239. DOI: 10.1210/endrev/bnab044.
|
| [17] |
QIN S, XU Y, YU S, ET AL. Molecular classification and tumor microenvironment characteristics in pheochromocytomas[J]. Elife, 2024, 12: RP87586. DOI: 10.7554/eLife.87586.
|
| [18] |
LIMA J V, KATER C E. The pheochromocytoma/paraganglioma syndrome: An overview on mechanisms, diagnosis and management[J]. International Braz Jurol: Official Journal of the Brazilian Society of Urology, 2023, 49(3): 307-319. DOI: 10.1590/S1677-5538.IBJU.2023.0038.
|
| [19] |
NOORTMAN W A, VRIENS D, DE GEUS-OEI LF, ET AL. [18F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas[J]. European Radiology, 2022, 32(10): 7227-7236. DOI: 10.1007/s00330-022-09034-5.
|
| [20] |
RYDER S J, LOVE A J, DUNCAN E L, ET AL. PET detectives: Molecular imaging for phaeochromocytomas and paragangliomas in the genomics era[J]. Clinical Endocrinology, 2021, 95(1): 13-28. DOI: 10.1111/cen.14375.
|
| [21] |
曹德宏, 范骏平, 朱梦丽, 等. 嗜铬细胞瘤/副神经节瘤诊疗的研究进展[J]. 现代泌尿外科杂志, 2023, 28(3): 254-260. DOI: 10.3969/j.issn.1009-8291.2023.03.016.
CAO D H, FAN J P, ZHU M L, ET AL. Research advances in the clinical diagnosis and treatment of pheochromocytoma and paranganglioma[J]. Journal of Modern Urology, 2023, 28(3): 254-260. DOI: 10.3969/j.issn.1009-8291.2023.03.016.
|
| [22] |
丁昌懋, 罗成龙, 张文志, 等. 平扫CT特征联合纹理分析鉴别经治乳腺癌患者肺部单发转移癌与原发腺癌[J]. 中国医学影像技术, 2022, 38(9): 1331-1335. DOI: 10.13929/j.issn.1003-3289.2022.09.012.
DING C M, LUO C L, ZHANG W Z, ET AL. Plain CT features combined with texture analysis for differentiating solitary pulmonary metastasis and lung adenocarcinoma inpatients with breast cancer after treatments[J]. Chinese Journal of Medical Imaging Technology, 2022, 38(9): 1331-1335. DOI: 10.13929/j.issn.1003-3289.2022.09.012.
|
| [23] |
李佳蔚, 张源, 刘文亚. 基于门静脉期CT图像3D纹理分析评估肝泡型棘球蚴病生物学活性[J]. 中国医学影像技术, 2023, 39(11): 1670-1674. DOI: 10.13929/j.issn.1003-3289.2023.11.016.
LI J W, ZHANG Y, LIU W Y, ET AL. 3D texture analysis based on portal vein phase CT images for evaluating biological activity of hepatic alveolar echinococcosis[J]. Chinese Journal of Medical Imaging Technology, 2023, 39(11): 1670-1674. DOI: 10.13929/j.issn.1003-3289.2023.11.016.
|
| [24] |
YU H, PARAKH A, BLAKE M, ET AL. Texture analysis as a radiomic marker for differentiating benign from malignant adrenal tumors[J]. Journal of Computer Assisted Tomography, 2020, 44(5): 766-771. DOI: 10.1097/RCT.0000000000001051.
|
| [25] |
SHI B, ZHANG G M, XU M, ET AL. Distinguishing metastases from benign adrenal masses: what can CT texture analysis do?[J]. Acta Radiologica, 2019, 60(11): 1553-1561. DOI: 10.1177/0284185119830292.
|
| [26] |
CRIMI F, QUAIA E, CABRELLE G, ET AL. Diagnostic accuracy of CT texture analysis in adrenal masses: A systematic review[J]. International Journal of Molecular Sciences, 2022, 23(2): 637. DOI: 10.3390/ijms23020637.
|
| [27] |
VAN BERKEL A, RAO J U, KUSTERS B, ET AL. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma[J]. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 2014, 55(8): 1253-1259. DOI: 10.2967/jnumed.114.137034.
|
| [28] |
DE LEO A, VARA G, PACCAPELO A, ET AL. Computerized tomography texture analysis of pheochromocytoma: Relationship with hormonal and histopathological data[J]. Journal of Endocrinological Investigation, 2022, 45(10): 1935-1944. DOI: 10.1007/s40618-022-01826-2.
|
| [29] |
GARCIA-CARBONERO R, MATUTE TERESA F, MERCADER-CIDONCHA E, et al. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas[J]. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, 23(10): 1995-2019. DOI: 10.1007/s12094-021-02622-9.
|
| [30] |
LI M, PRODANOV T, MEUTER L, ET AL. Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma[J]. The Journal of Clinical Endocrinology and Metabolism, 2023, 108(2): 397-404. DOI: 10.1210/clinem/dgac563.
|
| [31] |
THOMPSON L D. Pheochromocytoma of the adrenal gland scaled score to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases[J]. The American Journal of Surgical Pathology, 2002, 26: 551-566. DOI: 10.1097/00000478-200205000-00002.
|
| [32] |
KIMURA N, WATANABE T, NOSHIRO T, ET AL. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors[J]. Endocrine Pathology, 2005, 16: 23-32. DOI: 10.1385/ep:16:1:023.
|
| [33] |
PIERRE C, AGOPANTZ M, BRUNAUD L, ET AL. COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas[J]. Virchows Archiv: An International Journal of Pathology, 2019, 474(6): 721-734. DOI: 10.1007/s00428-019-02553-5.
|
| [34] |
ZHOU Y, ZHAN Y, ZHAO J, ET AL. CT-based radiomics analysis of different machine learning models for discriminating the risk stratification of pheochromocytoma and paraganglioma: A multicenter study[J]. Academic Radiology, 2024, 31(7): 2859-2871. DOI: 10.1016/j.acra.2024.01.008.
|
| [35] |
陈亚曦, 康文炎, 江长思, 等. 基于CT放射组学的机器学习模型预测肺腺癌气腔播散的研究[J]. 临床放射学杂志, 2023, 42(4): 606-610. DOI: 10.13437/j.cnki.jcr.2023.04.034.
CHEN Y X, KANG W Y, JIANG C S, et al. CT-based radiomics machine learning model to predict spread through air space in lung adenocarcinoma[J]. Journal of Clinical Radiology, 2024, 31(7): 2859-2871. DOI: 10.1016/j.acra.2024.01.008.
|
| [36] |
THEODOSIOU A A, READ R C. Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician[J]. The Journal of infection, 2023, 87(4): 287-294. DOI: 10.1016/j.jinf.2023.07.006.
|
| [37] |
SUN S, YAO W, WANG Y, ET AL. Development and validation of machine-learning models for the difficulty of retroperitoneal laparoscopic adrenalectomy based on radiomics[J]. Frontiers in Endocrinology, 2023, 14: 1265790. DOI: 10.3389/fendo.2023.1265790.
|
| [38] |
PAMPRAKI C, BERENDS A M A, FILIPPATOS A, ET AL. Prediction of metastatic pheochromocytoma and paraganglioma: A machine learning modelling study using data from a cross-sectional cohort[J]. The Lancet: Digital Health, 2023, 5(9): e551-e559. DOI: 10.1016/S2589-7500(23)00094-8.
|
| [39] |
尹辰琳, 栗瑞鸿, 刘晓滢, 等. 双层探测器光谱CT能谱图像在肾上腺乏脂腺瘤与转移瘤鉴别中的价值[J]. 临床放射学杂志, 2023, 42(7): 1169-1172. DOI: 10.13437/j.cnki.jcr.2023.07.003.
YIN C L, LI R H, LIU X Y, ET AL. The value of noncontrast images from dual-layer spectral detector CT for the differentiation of lipid-poor adrenal adenomas and metastases[J]. Journal of Clinical Radiology, 2023, 42(7): 1169-1172. DOI: 10.13437/j.cnki.jcr.2023.07.003.
|
| [40] |
金梅, 赵小梅, 徐雪, 等. 基于CT影像特征的早期肺腺癌脏层胸膜侵犯风险预测模型构建研究[J]. CT理论与应用研究(中英文), 2024, 33(4): 479-486. DOI: 10.15953/j.ctta.2023.107.
JIN M, ZHAO X M, XU X, ET AL. Risk-prediction model construction of visceral pleural invasion in early lung adenocarcinoma based on computed tomography imaging features[J]. CT Theory and Applications, 2024, 33(4): 479-486. DOI: 10.15953/j.ctta.2023.107.
|
| [41] |
BRANZOLI F, SALGUES B, MARJANSKA M, ET AL. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?[J]. Endocrine-related Cancer, 2023, 30(2): e220198. DOI: 10.1530/ERC-22-0198.
|
Supported by: Beijing Renhe Information Technology Co. Ltd 
DownLoad: